Annual Accounts Payable
$391.20 K
-$68.70 K-14.94%
December 1, 2022
Summary
- As of March 10, 2025, CERO annual accounts payable is $391.20 thousand, with the most recent change of -$68.70 thousand (-14.94%) on December 1, 2022.
- During the last 3 years, CERO annual accounts payable has fallen by -$68.70 thousand (-14.94%).
- CERO annual accounts payable is now -14.94% below its all-time high of $459.90 thousand, reached on December 1, 2021.
Performance
CERO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.67 M
+$319.80 K+5.04%
September 1, 2024
Summary
- As of March 10, 2025, CERO quarterly accounts payable is $6.67 million, with the most recent change of +$319.80 thousand (+5.04%) on September 1, 2024.
- Over the past year, CERO quarterly accounts payable has stayed the same.
- CERO quarterly accounts payable is now -5.56% below its all-time high of $7.06 million, reached on March 1, 2024.
Performance
CERO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CERO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.9% | 0.0% |
| 3 y3 years | -14.9% | 0.0% |
| 5 y5 years | -14.9% | 0.0% |
CERO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.9% | at low | -5.6% | +667.3% |
| 5 y | 5-year | -14.9% | at low | -5.6% | +667.3% |
| alltime | all time | -14.9% | at low | -5.6% | +667.3% |
CERo Therapeutics Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.67 M(+5.0%) |
| Jun 2024 | - | $6.35 M(-10.1%) |
| Mar 2024 | - | $7.06 M(+712.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $868.90 K |
| Dec 2022 | $391.20 K(-14.9%) | - |
| Dec 2021 | $459.90 K | - |
FAQ
- What is CERo Therapeutics Holdings annual accounts payable?
- What is the all time high annual accounts payable for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings annual accounts payable year-on-year change?
- What is CERo Therapeutics Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings quarterly accounts payable year-on-year change?
What is CERo Therapeutics Holdings annual accounts payable?
The current annual accounts payable of CERO is $391.20 K
What is the all time high annual accounts payable for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high annual accounts payable is $459.90 K
What is CERo Therapeutics Holdings annual accounts payable year-on-year change?
Over the past year, CERO annual accounts payable has changed by -$68.70 K (-14.94%)
What is CERo Therapeutics Holdings quarterly accounts payable?
The current quarterly accounts payable of CERO is $6.67 M
What is the all time high quarterly accounts payable for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high quarterly accounts payable is $7.06 M
What is CERo Therapeutics Holdings quarterly accounts payable year-on-year change?
Over the past year, CERO quarterly accounts payable has changed by $0.00 (0.00%)